CellType vs Deep Genomics
CellType vs Deep Genomics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellType is on 30/100 and Deep Genomics on 61/100.
Where each one leads
CellType
- agent readiness: 50/100 against 35/100
Deep Genomics
- our overall score: 61/100 against 30/100
- domain rating: 54/100 against 13/100
At a glance
| Measure | CellType | Deep Genomics |
|---|---|---|
| What it is | Agentic drug company using a 27B biological foundation model to simulate human cellular responses to drugs. | AI-powered biotechnology company developing RNA therapeutics for genetic diseases. |
| Category | Biotech, Drug Discovery, Computational Biology, Foundation Model | Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2023 | 2015 |
| Headquarters | San Francisco, United States | Toronto, Canada |
| Status | Active | Active |
Size, funding and growth
| Measure | CellType | Deep Genomics |
|---|---|---|
| Employees | Not published | 110 |
| Headcount growthLast 12 months | Not published | +19.3% |
| Total funding | Not published | $241M |
| Latest round | Not published | Series C |
| LinkedIn followers | Not published | 30,891 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellType | Deep Genomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 30/100 | 61/100 |
| Traction | Not published | 60/100 |
| Team | 10/100 | 60/100 |
| Search visibility | 15/100 | 33/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellType | Deep Genomics |
|---|---|---|
| Hosting | Vercel | Self Managed |
| CDN | Vercel | Not detected |
| Analytics | Not detected | Google Analytics 4, Segment |
CellType vs Deep Genomics: common questions
Which is better, CellType or Deep Genomics?
On our 0-100 score Deep Genomics rates higher (61/100 against 30/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do CellType and Deep Genomics compare on the numbers?
CellType leads on agent readiness (50/100 against 35/100). Deep Genomics leads on our overall score (61/100 against 30/100), domain rating (54/100 against 13/100).
Read the full CellType review and pricing or the Deep Genomics review and pricing. You can also browse other CellType alternatives we track.